http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2262788-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c405c2bfd90063e660a232cc17470ec |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-80 |
| filingDate | 1996-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5461226b4b9eda943eb46e242687a817 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9887be26a2269164ebd9b96653a3b038 |
| publicationDate | 1998-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2262788-A1 |
| titleOfInvention | Non-ulcerogenic analgesic/anti-inflammatory clonixin derivative |
| abstract | The clonixing derivative of formula (I), or 4-nitroxybutyl clonixate, is a novel non-steroidal analgesic-anti-inflammatory product that has an extraordinary good balance between high analgesic/anti-inflammatory activities and low ulcerogenic adverse effects, mainly as a consequence of a surprinsingly high anti-inflammatory activity (two times that of clonixic acid). Compound (I) is prepared by reaction of 4-chlorobutyl clonixate with silver nitrate in acetonitirle. 4-chlorobutyl clonixate is prepared by reaction of an alakaline clonixate with 1-bromo-4-chlorobutane in acetonitrile. 4-nitroxybutyl clonixate (I) is specially useful as an active principle for the treatment of pain and/or inflammation in mammals. |
| priorityDate | 1996-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.